[Federal Register Volume 76, Number 3 (Wednesday, January 5, 2011)]
[Notices]
[Pages 576-577]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-33287]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; SPORE in Mesothelioma, Lung, Breast and Ovarian Cancers.
    Date: February 2-3, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Wlodek Lopaczynski, M.D., PhD, Scientific Review 
Officer, Research Programs Review Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Blvd., Room 
8131, Bethesda, MD 20892, 301-594-1402, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Molecular Diagnostics Assay to Detect Basal-
like Breast Cancer.
    Date: February 15, 2011.
    Time: 12 p.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 703, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7141, Bethesda, MD 20892, 301-496-7575, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Systems for Automated Storage, Analysis, and Reporting of 
Objective Behavioral Exposures.
    Date: February 16-17, 2011.
    Time: 8:30 a.m. to 11 a.m.
    Agenda: To review and evaluate contract proposals.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Ellen K Schwartz, E.D.D., M.B.A., Scientific 
Review Officer, Special Review & Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-
1215, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Collaborative Research in Integrative Cancer Biology and the 
Tumor Microenvironment.
    Date: February 16, 2011.
    Time: 1 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8055A, Rockville, MD 20852, (Telephone Conference Call)
    Contact Person: Zhiqiang Zou, M.D., PhD, Scientific Review 
Officer, National Cancer Institute, National Institutes of Health, 
6116 Executive Blvd., Room 8055A, MSC 8329, Bethesda, MD 20852, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Smartphone Applications for Cancer Prevention and Control.
    Date: February 17, 2011.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Ellen K Schwartz, E.D.D., M.B.A., Scientific 
Review Officer, Special Review & Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-
1215, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Nanotechnology Sensing Platforms.
    Date: March 2, 2011.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Savvas C Makrides, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 
8050a, Bethesda, MD 20892, 301-496-7421, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Innovative Technology Development.
    Date: March 2-3, 2011.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Jeffrey E. DeClue, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 8059, Bethesda, MD 20892-8329, 301-496-7904, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel;

[[Page 577]]

Nanotechnology Therapeutics and Theranostics.
    Date: March 3, 2011.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Savvas C Makrides, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm 
8050a, Bethesda, MD 20892, 301-496-7421, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Development of Blood-based Methods for the Detection of 
Cancer Recurrence in Post-Therapy Breast Cancer Patients.
    Date: March 3, 2011.
    Time: 12 p.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 703, Rockville, MD 20852, (Telephone Conference Call)
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7141, Bethesda, MD 20892, 301-496-7575, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; High Level Programming Language to Expedite Development of 
User Interfaces.
    Date: March 8, 2011.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 607, Rockville, MD 20852, (Telephone Conference Call)
    Contact Person: Marvin L. Salin, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Non-Coding RNAs and Cancer.
    Date: March 10, 2011.
    Time: 8 a.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Thomas M Vollberg, PhD, Scientific Review 
Officer, Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, 6116 Executive Boulevard, 
Room 7142, Bethesda, MD 20892, 301-594-9582, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Health Information Technology to Facilitate Patient-Centered 
Communication in Cancer Related Care.
    Date: March 10, 2011.
    Time: 12 p.m. to 3 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 607, Rockville, MD 20852, (Telephone Conference Call)
    Contact Person: Marvin L. Salin, PhD, Scientific Review Officer, 
Special Review and Logistics Branch, Division of Extramural 
Activities, National Cancer Institute, NIH, 6116 Executive 
Boulevard, Room 7073, Bethesda, MD 20892-8329, 301-496-0694, 
[email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Multi-Center Clinical Trials.
    Date: March 14, 2011.
    Time: 2 p.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Room 8103, Rockville, MD 20852, (Telephone Conference Call)
    Contact Person: Timothy C. Meeker, M.D., PhD, Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: December 28, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-33287 Filed 1-4-11; 8:45 am]
BILLING CODE 4140-01-P